EC Number | Cloned (Comment) | Organism |
---|---|---|
1.1.1.51 | overexpression of type 3 17beta-HSD in HEK-293 cells | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.51 | additional information | design, synthesis and in vitro evaluation of 4-androstene-3,17-dione/adenosine hybrid compounds as bisubstrate inhibitors of type 3 17beta-HSD, the bisubstrate inhibitors are less potent in intact cells than in homogenated cells, overview, the best inhibitors of that series are those bearing an alkyl side-chain spacer of 11 or 12 methylenes with inhibition of 69% and 78% at 1 mM | Homo sapiens |
EC Number | KM Value [mM] | KM Value Maximum [mM] | Substrate | Comment | Organism | Structure |
---|---|---|---|---|---|---|
1.1.1.62 | 0.0035 | - |
estrone | type 12 17beta-hydroxysteroid dehydrogenase | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.51 | additional information | Homo sapiens | the enzyme is an important therapeutic target for androgen-sensitive diseases, overview | ? | - |
? | |
1.1.1.62 | estrone + NAD(P)H + H+ | Homo sapiens | type 12 17beta-hydroxysteroid dehydrogenase plays a role in estrogen formation. Type 12 17beta-hydroxysteroid dehydrogenase is the major estrogenic 17beta-HSD responsible for the conversion of estrone to estradiol in women, especially in the ovary, the predominant source of estrogens before menopause | estradiol + NAD(P)+ | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
1.1.1.51 | Homo sapiens | - |
- |
- |
1.1.1.62 | Homo sapiens | Q53GQ0 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
1.1.1.62 | HEK-293 cell | stable expressing 17beta-HSD12 | Homo sapiens | - |
1.1.1.62 | mammary gland | - |
Homo sapiens | - |
1.1.1.62 | ovary | type 12 17beta-hydroxysteroid dehydrogenase is most highly expressed in ovary and mammary gland | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
1.1.1.51 | 4-androstene-3,17-dione + NADPH + H+ | selective reduction at C17 | Homo sapiens | testosterone + NADP+ | - |
? | |
1.1.1.51 | additional information | the enzyme is an important therapeutic target for androgen-sensitive diseases, overview | Homo sapiens | ? | - |
? | |
1.1.1.62 | estrone + NAD(P)H + H+ | type 12 17beta-hydroxysteroid dehydrogenase plays a role in estrogen formation. Type 12 17beta-hydroxysteroid dehydrogenase is the major estrogenic 17beta-HSD responsible for the conversion of estrone to estradiol in women, especially in the ovary, the predominant source of estrogens before menopause | Homo sapiens | estradiol + NAD(P)+ | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
1.1.1.51 | 17beta-HSD | - |
Homo sapiens |
1.1.1.51 | type 3 17beta-HSD | - |
Homo sapiens |
1.1.1.51 | type 3 17beta-hydroxysteroid dehydrogenase | - |
Homo sapiens |
1.1.1.62 | 17beta-HSD12 | - |
Homo sapiens |
1.1.1.62 | type 12 17beta-hydroxysteroid dehydrogenase | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
1.1.1.51 | NADPH | - |
Homo sapiens |